Metis Global Partners, LLC Baxter International Inc Transaction History

Metis Global Partners, LLC

$2.87 Billion
Q2 2024

A detailed history of Metis Global Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 16,863 shares of BAX stock, worth $663,896. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,863

Previous 16,829 0.2%

Holding current value

$663,896

Previous $719,000 21.56%

% of portfolio

0.02%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$32.87 - $43.55 $1,117 - $1,480	34 Added 0.2%	16,863 $564,000
Q1 2024 May 06, 2024	SELL	$37.88 - $43.77 $7,765 - $8,972	-205 Reduced 1.2%	16,829 $719,000
Q4 2023 Feb 06, 2024	SELL	$31.71 - $38.95 $57,680 - $70,850	-1,819 Reduced 9.65%	17,034 $658,000
Q3 2023 Nov 07, 2023	BUY	$37.32 - $49.29 $122,484 - $161,769	3,282 Added 21.08%	18,853 $711,000
Q2 2023 Aug 07, 2023	SELL	$39.98 - $47.68 $211,614 - $252,370	-5,293 Reduced 25.37%	15,571 $709,000
Q1 2023 May 08, 2023	BUY	$37.58 - $52.57 $249,418 - $348,907	6,637 Added 46.65%	20,864 $846,000
Q4 2022 Feb 07, 2023	BUY	$49.7 - $57.71 $331,996 - $385,502	6,680 Added 88.51%	14,227 $725,000
Q3 2022 Nov 08, 2022	SELL	$53.86 - $66.8 $1,508 - $1,870	-28 Reduced 0.37%	7,547 $406,000
Q2 2022 Aug 08, 2022	SELL	$63.83 - $80.0 $21,893 - $27,440	-343 Reduced 4.33%	7,575 $486,000
Q1 2022 May 03, 2022	BUY	$76.85 - $89.45 $273,278 - $318,084	3,556 Added 81.52%	7,918 $613,000
Q4 2021 Feb 11, 2022	BUY	$74.57 - $87.19 $325,274 - $380,322	4,362 New	4,362 $374,000

Others Institutions Holding BAX

# of Institutions

981

Shares Held

446M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Account

Metis Global Partners, LLC Baxter International Inc Transaction History